# Autonomous Healthcare

> Autonomous Healthcare builds intelligent systems for critical care — from intelligent-algorithm surveillance of mechanical ventilation to closed-loop control of drug delivery. Its Syncron-E™ system is the first system granted FDA marketing authorization (De Novo) for detecting ineffective effort, the most frequent type of patient-ventilator asynchrony.

The founding team brings together backgrounds in aerospace engineering and critical care medicine. The company's mission is to build autonomous systems that give every ICU patient the vigilance they deserve.

## Products

- [Syncron-E™](https://www.autonomoushealthcare.com/syncron-e.html): Waveform intelligence for mechanical ventilation. Analyzes ventilator pressure and flow waveforms breath-by-breath to detect patient-ventilator asynchrony, with a focus on ineffective efforts. FDA De Novo granted.
- [E-Fusion™](https://www.autonomoushealthcare.com/e-fusion.html): Closed-loop control system for drug delivery, using feedback architecture to maintain hemodynamic targets. In development.

## Company

- [About](https://www.autonomoushealthcare.com/about.html): Mission and leadership team, including co-founders Wassim M. Haddad, PhD (Chairman, Chief Scientific Advisor) and Behnood Gholami, PhD (CEO).
- [News](https://www.autonomoushealthcare.com/news.html): Press releases and media coverage, including features in IEEE Spectrum and NIH grant awards.
- [Contact](mailto:info@autonomoushealthcare.com): info@autonomoushealthcare.com